New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
16:17 EDTBLUEbluebird bio reports Q2 EPS (6c), consensus (45c)
Reports Q2 revenue $6.34M, consensus $6.15M. Anticipated 2014 milestones: Present further clinical results in beta-thalassemia major from HGB-205 and Northstar Studies in late 2014 and transplant first sickle cell disease patient with LentiGlobin product candidate.
News For BLUE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
07:16 EDTBLUEPiper Jaffray and the Alliance for Regenerative Medicine co-host conference
3rd Annual Regenerative Medicine Investor Day is being held in New York on March 25 with webcasted company presentations to begin at 8 am; not all company presentations may be webcasted. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use